Virology News and Research

Latest Virology News and Research

Americans' hand-washing habits has not changed despite H1N1 virus reveals a national survey

Worries about the H1N1 virus haven't changed most Americans' hand washing habits, says a national survey by Bradley Corporation, a leading manufacturer of commercial bathroom and locker room furnishings.

25 Aug 2009

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

A sanitising spray that kills 99.99% of Viruses, Bacteria and Germs is now available for purchase in the UK. The SaniGuard wipes, spray and fogger products were invented by David Morgan, president of DEM Technology in the United States. After patenting the product he was awarded EPA registration for its use on food contact surfaces in 1996.

25 Aug 2009

NCI investigator’s endorsement of of inaccurate high-risk HPV test to refer women to cervical cancer tests is “unfortunate and inappropriate” says Sin Hang Lee

A National Cancer Institute (NCI) investigator’s endorsement of inaccurate high-risk HPV test to refer women to cervical cancer tests, despite the weak evidence of its value, is “unfortunate and inappropriate.”

25 Aug 2009

Unotron collaborates with GHA Technologies to supply washable data input devices

School systems throughout the nation have a strong ally in mitigating a resurgence of swine flu this fall. UNOTRON (www.unotron.com), worldwide creator of medical grade, washable computer keyboards, scroll wheel mice, and smartcard readers, announces that it is teaming up with GHA Technologies, Inc. (www.gha-associates.com) to offer Unotron’s high quality, washable data input and security devices.

25 Aug 2009

TIME examines discrimination against HIV-positive children in Vietnam

TIME examines the discriminatory efforts to keep Vietnamese children living with HIV out of the country's public schools even though, by law, "[c]hildren cannot be barred from school because they or any of their family members have HIV/AIDS."

25 Aug 2009

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).

25 Aug 2009

USDA donates funds for teaching food safety awareness to AIDS patients

Researchers at the University of Illinois at Chicago School of Public Health have received a grant from the U.S. Department of Agriculture to educate AIDS patients on food safety.

25 Aug 2009

INSERM researchers engineer a chimeric protein that improves stem cell engraftment

Researchers at INSERM (France) have engineered a chimeric protein that increases cell survival, migration and proliferation to improve stem cell engraftment. The results, which appear in the September 2009 issue of Experimental Biology and Medicine, show that TAT-Tpr-Met, a cell permeable form of the hepatocyte growth factor receptor can increase the number of hepatic stem cells integrated into the liver of the mouse.

24 Aug 2009

WHO appeals for donated, low-cost H1N1 vaccines

The WHO's flu chief Keiji Fukuda on Saturday called upon wealthy nations and vaccine manufacturers to donate H1N1 (swine) flu vaccines to developing countries, the Associated Press reports.

24 Aug 2009

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

24 Aug 2009

CSL Biotherapies initiates clinical trials of Influenza A/H1N1 2009 vaccine in the US

CSL Biotherapies has announced the initiation of the company’s first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL’s candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.

24 Aug 2009

Advisory labels to help combat swine flu

Out With Allergies LLC has announced the introduction of FluNotes(TM), "Wash Hands Fight Flu"(TM) advisory labels as a potent new weapon for combating swine flu. Available through their website, www.FluNotes.com, these stick-on notes are intended to make people more aware that they must wash their hands frequently to avoid catching and spreading the flu.

24 Aug 2009

National campaign to educate people with developmental disabilities about protection from germs

The Tech-Aid Institute, http://www.techaidinstitute.com, is launching a national campaign to educate people with intellectual and other developmental disabilities about how to protect themselves from germs that include the 2009 flu pandemic that is commonly known as the Swine (H1N1) Flu.

24 Aug 2009

Researchers discover elusive nanoscale movements of ribosomes at work

Researchers at the University of California, Berkeley, have for the first time captured elusive nanoscale movements of ribosomes at work, shedding light on how these cellular factories take in genetic instructions and amino acids to churn out proteins.

24 Aug 2009

Microbiologists discover new therapies for human respiratory syncytial virus and influenza A virus

A cellular molecule that not only can sense two common respiratory viruses but also can direct cells to mount a defense has been identified by microbiologists at The University of Texas Health Science Center at San Antonio.

24 Aug 2009

Marin Catholic High School's new SAS system reduces the presence of illness-causing microorganisms

Marin Catholic High School (MCHS) and CSG, the worldwide leader in environmentally-beneficial surface treatments, today announced the school is the Bay Area's first education facility to integrate the Surface Antimicrobial System (SAS). The most environmentally friendly and long-lasting treatment of its kind, SAS has transformed 10,000 square feet of high-touch surfaces in Marin's athletic facility into materials that continuously inhibit the growth of harmful bacteria, mold, and fungi for three years.

24 Aug 2009

Nervous system integrity could play a central role in preventing prion diseases

A new study shows that nervous system integrity and axonal properties may play a key role in prion diseases. The findings, from researchers at the Rudolf Virchow Center and the Institute of Virology of the University of W-rzburg, expand our understanding of the development of prion disease and suggest novel targets for therapeutic and diagnostic approaches in its early stages.

24 Aug 2009

'Explosion' of H1N1 cases likely, WHO Says

In the coming months, countries should prepare for an "explosion" in new cases of H1N1 (swine) flu until peak transmission of the virus is reached, WHO Western Pacific Director Shin Young-soo told a symposium of health officials gathered in Beijing Friday, the Associated Press reports.

23 Aug 2009

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).

22 Aug 2009

Applied Nanoscience in joint venture agreement to produce disposable protective face mask

Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced it has reached a joint venture agreement to begin production on a disposable protective face mask with its Asia Pacific region partner. The protective mask will incorporate ANI's proprietary NanoFense™ technology, a U.S. patent pending antimicrobial nanoparticle formulation.

21 Aug 2009

Virology News and Research

Latest Virology News and Research

Americans' hand-washing habits has not changed despite H1N1 virus reveals a national survey

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

NCI investigator’s endorsement of of inaccurate high-risk HPV test to refer women to cervical cancer tests is “unfortunate and inappropriate” says Sin Hang Lee

Unotron collaborates with GHA Technologies to supply washable data input devices

TIME examines discrimination against HIV-positive children in Vietnam

NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug

USDA donates funds for teaching food safety awareness to AIDS patients

INSERM researchers engineer a chimeric protein that improves stem cell engraftment

WHO appeals for donated, low-cost H1N1 vaccines

Retigabine's Phase IIa clinical trial preliminary results announced

CSL Biotherapies initiates clinical trials of Influenza A/H1N1 2009 vaccine in the US

Advisory labels to help combat swine flu

National campaign to educate people with developmental disabilities about protection from germs

Researchers discover elusive nanoscale movements of ribosomes at work

Microbiologists discover new therapies for human respiratory syncytial virus and influenza A virus

Marin Catholic High School's new SAS system reduces the presence of illness-causing microorganisms

Nervous system integrity could play a central role in preventing prion diseases

'Explosion' of H1N1 cases likely, WHO Says

Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug

Applied Nanoscience in joint venture agreement to produce disposable protective face mask

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation